John Maraganore

Affiliations

  • at Kymera Therapeutics Inc. (KYMR), 2025-06-27
  • at Rapport Therapeutics Inc. (RAPP), 2025-06-18
  • at Beam Therapeutics Inc. (BEAM), 2025-06-06
  • Director at Prokidney Corp. (PROK), 2023-07-03
  • Director at Agios Pharmaceuticals Inc. (AGIO), 2023-02-03
  • Chief Executive Officer at Alnylam Pharmaceuticals Inc. (ALNY), 2021-12-23
  • Director at Bluebird Bio Inc. (BLUE), 2017-09-18
  • Large Shareholder, Director at Regulus Therapeutics Inc. (RGLS), 2012-10-11
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ALNY $95.00 10,000 $950,000.00 122,825 2015-01-26 Filing
BLUE $85.00 2,352 $199,920.00 5,293 2014-12-19 Filing
AGIO $110.75 1,806 $200,014.50 50,689 2014-12-16 Filing
BLUE $34.00 2,941 $99,994.00 2,941 2014-07-14 Filing
AGIO $43.98 2,300 $101,154.00 48,883 2014-06-23 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ALNY $174.34 670 $116,807.80 214,765 2021-11-12 Filing
ALNY $173.25 683 $118,329.75 215,435 2021-11-12 Filing
ALNY $172.22 14,518 $2,500,289.96 216,118 2021-11-12 Filing
ALNY $171.35 7,742 $1,326,591.70 230,636 2021-11-12 Filing
ALNY $170.36 10,365 $1,765,781.40 238,378 2021-11-12 Filing